30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Outset Medical Inc (OM)

Track

Over the last 90 days, Outset Medical Inc. has seen net insider selling totaling $115,660.18, with executives accounting for the entire amount. A total of 8 transactions were recorded, all of which were sales. The company's stock has experienced a 39.7% increase in the past 90 days, and the last earnings report missed expectations by 5.06%.
Stock chart
Ticker: OM Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gaeta Renee
Chief Financial Officer
2 sales — total 187,385 USD
Sale 3 Jun 2026
Value US$3,613,207.97 | Price 235.73 | Shares 74,155
Proposed sale 3 Jun 2026
Value US$2,905,405.75 | Price 89.98 | Shares 25,663
Sale 15 May 2026
Value US$3,707,573.66 | Price 370.68 | Shares 73,288
Proposed sale 15 May 2026
Value US$4,518,027.46 | Price 173.08 | Shares 70,509
Sale 15 May 2026
Value US$9,760.60 | Price 3.70 | Shares 2,638
Proposed sale 15 May 2026
Value US$9,760.60 | Price 3.70 | Shares 2,638
Sale 15 May 2026
Value US$12,746.50 | Price 3.70 | Shares 3,445
Proposed sale 15 May 2026
Value US$12,746.50 | Price 3.70 | Shares 3,445
Sale 17 Feb 2026
Value US$9,520.70 | Price 3.35 | Shares 2,842
Proposed sale 17 Feb 2026
Value US$9,520.70 | Price 3.35 | Shares 2,842
Sale 17 Feb 2026
Value US$11,259.35 | Price 3.35 | Shares 3,361
Proposed sale 17 Feb 2026
Value US$11,259.35 | Price 3.35 | Shares 3,361
Sale 17 Feb 2026
Value US$6,086.95 | Price 3.35 | Shares 1,817
Proposed sale 21 Jan 2026
Value US$10,696.59 | Price 5.05 | Shares 2,120
Sale 21 Jan 2026
Value US$10,706.00 | Price 5.05 | Shares 2,120
Proposed sale 21 Jan 2026
Value US$4,876.11 | Price 4.98 | Shares 980
Sale 21 Jan 2026
Value US$4,880.40 | Price 4.98 | Shares 980
Proposed sale 21 Jan 2026
Value US$5,913.82 | Price 5.01 | Shares 1,180
Sale 21 Jan 2026
Value US$5,911.80 | Price 5.01 | Shares 1,180
Sale 20 Jan 2026
Value US$47,687.68 | Price 5.12 | Shares 9,314
Proposed sale 20 Jan 2026
Value US$47,682.76 | Price 5.12 | Shares 9,314
Sale 20 Jan 2026
Value US$27,520.00 | Price 5.12 | Shares 5,375
Proposed sale 20 Jan 2026
Value US$27,520.00 | Price 5.12 | Shares 5,375
Sale 20 Jan 2026
Value US$60,385.28 | Price 5.12 | Shares 11,794
Proposed sale 20 Jan 2026
Value US$60,385.28 | Price 5.12 | Shares 11,794
Sale 7 Jan 2026
Value US$461.16 | Price 4.27 | Shares 108
Proposed sale 7 Jan 2026
Value US$461.16 | Price 4.27 | Shares 108
Sale 7 Jan 2026
Value US$7,664.65 | Price 4.27 | Shares 1,795
Proposed sale 7 Jan 2026
Value US$7,664.65 | Price 4.27 | Shares 1,795
Sale 7 Jan 2026
Value US$956.48 | Price 4.27 | Shares 224
Proposed sale 7 Jan 2026
Value US$956.48 | Price 4.27 | Shares 224
Sale 1 Dec 2025
Value US$6,764.76 | Price 4.37 | Shares 1,548
Sale 17 Nov 2025
Value US$1,136.20 | Price 4.60 | Shares 247
Proposed sale 17 Nov 2025
Value US$1,136.20 | Price 4.60 | Shares 247
Sale 17 Nov 2025
Value US$1,784.80 | Price 4.60 | Shares 388
Proposed sale 17 Nov 2025
Value US$1,784.80 | Price 4.60 | Shares 388
Sale 17 Nov 2025
Value US$4,213.60 | Price 4.60 | Shares 916
Proposed sale 17 Nov 2025
Value US$4,213.60 | Price 4.60 | Shares 916
Sale 15 Aug 2025
Value US$3,129.84 | Price 12.88 | Shares 243
Proposed sale 15 Aug 2025
Value US$3,129.84 | Price 12.88 | Shares 243
Sale 15 Aug 2025
Value US$11,643.52 | Price 12.88 | Shares 904
Proposed sale 15 Aug 2025
Value US$11,643.52 | Price 12.88 | Shares 904
Sale 15 Aug 2025
Value US$4,933.04 | Price 12.88 | Shares 383
Proposed sale 15 Aug 2025
Value US$4,933.04 | Price 12.88 | Shares 383
Planned sale 15 May 2025
Value US$4,490.64 | Price 17.82 | Shares 252
Proposed sale 15 May 2025
Value US$4,490.50 | Price 17.82 | Shares 252
Planned sale 15 May 2025
Value US$16,643.00 | Price 17.80 | Shares 935
Proposed sale 15 May 2025
Value US$16,646.12 | Price 17.80 | Shares 935
Sale 15 May 2025
Value US$7,056.72 | Price 17.82 | Shares 396
Proposed sale 15 May 2025
Value US$7,057.86 | Price 17.82 | Shares 396
Sale 15 May 2025
Value US$10,401.04 | Price 17.81 | Shares 584
Proposed sale 15 May 2025
Value US$10,405.03 | Price 17.82 | Shares 584
Sale 18 Feb 2025
Value US$13,149.90 | Price 0.90 | Shares 14,611
Proposed sale 18 Feb 2025
Value US$13,149.90 | Price 0.90 | Shares 14,611
Sale 18 Feb 2025
Value US$7,793.10 | Price 0.90 | Shares 8,659
Proposed sale 18 Feb 2025
Value US$7,793.10 | Price 0.90 | Shares 8,659
Sale 18 Feb 2025
Value US$5,530.50 | Price 0.90 | Shares 6,145
Proposed sale 18 Feb 2025
Value US$5,530.50 | Price 0.90 | Shares 6,145
Sale 18 Feb 2025
Value US$3,783.60 | Price 0.90 | Shares 4,204
Proposed sale 18 Feb 2025
Value US$3,783.60 | Price 0.90 | Shares 4,204
Sale 21 Jan 2025
Value US$2,143.20 | Price 0.80 | Shares 2,679
Sale 21 Jan 2025
Value US$23,579.20 | Price 0.80 | Shares 29,474
Sale 21 Jan 2025
Value US$621.60 | Price 0.80 | Shares 777
Sale 21 Jan 2025
Value US$243.20 | Price 0.80 | Shares 304
Sale 21 Jan 2025
Value US$776.80 | Price 0.80 | Shares 971
Sale 21 Jan 2025
Value US$17,272.00 | Price 0.80 | Shares 21,590
Sale 21 Jan 2025
Value US$284.80 | Price 0.80 | Shares 356
Proposed sale 21 Jan 2025
Value US$18,576.80 | Price 0.80 | Shares 23,221
Sale 21 Jan 2025
Value US$3,125.60 | Price 0.80 | Shares 3,907
Sale 21 Jan 2025
Value US$23,579.20 | Price 0.80 | Shares 29,474
Sale 21 Jan 2025
Value US$725.60 | Price 0.80 | Shares 907
Sale 21 Jan 2025
Value US$14,759.20 | Price 0.80 | Shares 18,449
Sale 21 Jan 2025
Value US$33,907.20 | Price 0.80 | Shares 42,384
Sale 21 Jan 2025
Value US$3,522.40 | Price 0.80 | Shares 4,403
Proposed sale 21 Jan 2025
Value US$52,188.80 | Price 0.80 | Shares 65,236
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-03 S Sale
Gaeta Renee

Chief Financial Officer

Officer
74,155 -5.6%
235.73
US$3,613,208 		74,155 -5.6% 235.73 US$3,613,208
2026-06-03 2026-06-03 PrS Proposed sale
Gaeta Renee

Officer

Officer
25,663
89.98
US$2,905,406 		25,663 89.98 US$2,905,406
2026-05-19 2026-05-15 S Sale
3.8
Nash Marc

EVP Operations R&D & Service

Officer
73,288 -25.2%
370.68
US$3,707,574 		73,288 -25.2% 370.68 US$3,707,574
2026-05-19 2026-05-15 S Sale
3.8
Brottem John L.

General Counsel

Officer
2,638 -8.0%
3.70
US$9,761 		2,638 -8.0% 3.70 US$9,761
2026-05-19 2026-05-15 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
3,445 -3.4%
3.70
US$12,746 		3,445 -3.4% 3.70 US$12,746
2026-05-15 2026-05-15 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
3,445
3.70
US$12,746 		3,445 3.70 US$12,746
2026-05-15 2026-05-15 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
1,582
3.70
US$5,853 		1,582 3.70 US$5,853
2026-05-15 2026-05-15 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
2,638
3.70
US$9,761 		2,638 3.70 US$9,761
2026-02-19 2026-02-17 S Sale
3.8
Brottem John L.

General Counsel

Officer
2,842 -7.9%
3.35
US$9,521 		2,842 -7.9% 3.35 US$9,521
2026-02-19 2026-02-17 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
3,361 -3.2%
3.35
US$11,259 		3,361 -3.2% 3.35 US$11,259
2026-02-19 2026-02-17 S Sale
3.8
Nash Marc

EVP Operations R&D & Service

Officer
1,817 -4.3%
3.35
US$6,087 		1,817 -4.3% 3.35 US$6,087
2026-02-17 2026-02-17 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
3,361
3.35
US$11,259 		3,361 3.35 US$11,259
2026-02-17 2026-02-17 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
2,842
3.35
US$9,521 		2,842 3.35 US$9,521
2026-01-21 2026-01-21 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
2,120
5.05
US$10,697 		2,120 5.05 US$10,697
2026-01-21 2026-01-21 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
980
4.98
US$4,876 		980 4.98 US$4,876
2026-01-21 2026-01-21 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
1,180
5.01
US$5,914 		1,180 5.01 US$5,914
2026-01-21 2026-01-21 S Sale
3.8
Brottem John L.

General Counsel

Officer
1,180 -3.2%
5.01
US$5,912 		1,180 -3.2% 5.01 US$5,912
2026-01-21 2026-01-21 S Sale
3.8
Nash Marc

EVP Operations R&D & Service

Officer
980 -2.3%
4.98
US$4,880 		980 -2.3% 4.98 US$4,880
2026-01-21 2026-01-21 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
2,120 -2.0%
5.05
US$10,706 		2,120 -2.0% 5.05 US$10,706
2026-01-21 2026-01-20 S Sale
3.8
Brottem John L.

General Counsel

Officer
9,314 -20.1%
5.12
US$47,688 		9,314 -20.1% 5.12 US$47,688
2026-01-21 2026-01-20 S Sale
3.8
Nash Marc

EVP Operations R&D & Service

Officer
5,375 -11.2%
5.12
US$27,520 		5,375 -11.2% 5.12 US$27,520
2026-01-21 2026-01-20 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
11,794 -9.9%
5.12
US$60,385 		11,794 -9.9% 5.12 US$60,385
2026-01-20 2026-01-20 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
5,375
5.12
US$27,520 		5,375 5.12 US$27,520
2026-01-20 2026-01-20 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
11,794
5.12
US$60,385 		11,794 5.12 US$60,385
2026-01-20 2026-01-20 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
9,314
5.12
US$47,683 		9,314 5.12 US$47,683
2026-01-08 2026-01-07 S Sale
3.8
Nash Marc

EVP Operations R&D & Service

Officer
108 -0.2%
4.27
US$461 		108 -0.2% 4.27 US$461
2026-01-08 2026-01-07 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
1,795 -1.5%
4.27
US$7,665 		1,795 -1.5% 4.27 US$7,665
2026-01-08 2026-01-07 S Sale
3.8
Brottem John L.

General Counsel

Officer
224 -0.5%
4.27
US$956 		224 -0.5% 4.27 US$956
2026-01-07 2026-01-07 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
108
4.27
US$461 		108 4.27 US$461
2026-01-07 2026-01-07 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
1,795
4.27
US$7,665 		1,795 4.27 US$7,665
2026-01-07 2026-01-07 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
224
4.27
US$956 		224 4.27 US$956
2025-12-02 2025-12-01 S Sale
2.9
Drexler Karen
Non-Executive Director
1,548 -12.7%
4.37
US$6,765 		1,548 -12.7% 4.37 US$6,765
2025-11-18 2025-11-17 S Sale
3.8
Nash Marc

EVP Operations R&D & Service

Officer
247 -0.5%
4.60
US$1,136 		247 -0.5% 4.60 US$1,136
2025-11-18 2025-11-17 S Sale
3.8
Brottem John L.

General Counsel

Officer
388 -0.8%
4.60
US$1,785 		388 -0.8% 4.60 US$1,785
2025-11-18 2025-11-17 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
916 -0.7%
4.60
US$4,214 		916 -0.7% 4.60 US$4,214
2025-11-17 2025-11-17 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
247
4.60
US$1,136 		247 4.60 US$1,136
2025-11-17 2025-11-17 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
916
4.60
US$4,214 		916 4.60 US$4,214
2025-11-17 2025-11-17 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
388
4.60
US$1,785 		388 4.60 US$1,785
2025-08-18 2025-08-15 S Sale
3.8
Nash Marc

SVP Operations and R&D

Officer
243 -0.6%
12.88
US$3,130 		243 -0.6% 12.88 US$3,130
2025-08-18 2025-08-15 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
904 -0.7%
12.88
US$11,644 		904 -0.7% 12.88 US$11,644
2025-08-18 2025-08-15 S Sale
3.8
Brottem John L.

General Counsel

Officer
383 -0.8%
12.88
US$4,933 		383 -0.8% 12.88 US$4,933
2025-08-15 2025-08-15 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
904
12.88
US$11,644 		904 12.88 US$11,644
2025-08-15 2025-08-15 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
383
12.88
US$4,933 		383 12.88 US$4,933
2025-08-15 2025-08-15 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
243
12.88
US$3,130 		243 12.88 US$3,130
2025-05-16 2025-05-15 PlS Planned sale
3.8
Nash Marc

SVP Operations and R&D

Officer
252 -1.8%
17.82
US$4,491 		252 -1.8% 17.82 US$4,491
2025-05-16 2025-05-15 PlS Planned sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
935 -1.6%
17.80
US$16,643 		935 -1.6% 17.80 US$16,643
2025-05-16 2025-05-15 S Sale
3.8
Brottem John L.

General Counsel

Officer
396 -3.4%
17.82
US$7,057 		396 -3.4% 17.82 US$7,057
2025-05-16 2025-05-15 S Sale
4.1
Ahmed Nabeel

Chief Financial Officer

Officer
584 -3.5%
17.81
US$10,401 		584 -3.5% 17.81 US$10,401
2025-05-15 2025-05-15 PrS Proposed sale
4.1
Ahmed Nabeel

Officer

Officer
584
17.82
US$10,405 		584 17.82 US$10,405
2025-05-15 2025-05-15 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
935
17.80
US$16,646 		935 17.80 US$16,646
2025-05-15 2025-05-15 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
396
17.82
US$7,058 		396 17.82 US$7,058
2025-05-15 2025-05-15 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
252
17.82
US$4,490 		252 17.82 US$4,490
2025-02-19 2025-02-18 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
14,611 -1.6%
0.90
US$13,150 		14,611 -1.6% 0.90 US$13,150
2025-02-19 2025-02-18 S Sale
4.1
Ahmed Nabeel

Chief Financial Officer

Officer
8,659 -3.3%
0.90
US$7,793 		8,659 -3.3% 0.90 US$7,793
2025-02-19 2025-02-18 S Sale
3.8
Brottem John L.

General Counsel

Officer
6,145 -3.4%
0.90
US$5,530 		6,145 -3.4% 0.90 US$5,530
2025-02-19 2025-02-18 S Sale
3.8
Nash Marc

SVP Operations and R&D

Officer
4,204 -2.1%
0.90
US$3,784 		4,204 -2.1% 0.90 US$3,784
2025-02-18 2025-02-18 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
14,611
0.90
US$13,150 		14,611 0.90 US$13,150
2025-02-18 2025-02-18 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
4,204
0.90
US$3,784 		4,204 0.90 US$3,784
2025-02-18 2025-02-18 PrS Proposed sale
3.8
Brottem John L.

Officer

Officer
6,145
0.90
US$5,530 		6,145 0.90 US$5,530
2025-02-18 2025-02-18 PrS Proposed sale
4.1
Ahmed Nabeel

Officer

Officer
8,659
0.90
US$7,793 		8,659 0.90 US$7,793
2025-01-22 2025-01-21 S Sale
3.8
Brottem John L.

General Counsel

Officer
2,679 -1.5%
0.80
US$2,143 		2,679 -1.5% 0.80 US$2,143
2025-01-22 2025-01-21 S Sale
3.8
Brottem John L.

General Counsel

Officer
29,474 -13.8%
0.80
US$23,579 		29,474 -13.8% 0.80 US$23,579
2025-01-22 2025-01-21 S Sale
3.8
Brottem John L.

General Counsel

Officer
777 -0.4%
0.80
US$622 		777 -0.4% 0.80 US$622
2025-01-22 2025-01-21 S Sale
3.8
Nash Marc

SVP Operations and R&D

Officer
304 -0.1%
0.80
US$243 		304 -0.1% 0.80 US$243
2025-01-22 2025-01-21 S Sale
3.8
Nash Marc

SVP Operations and R&D

Officer
971 -0.5%
0.80
US$777 		971 -0.5% 0.80 US$777
2025-01-22 2025-01-21 S Sale
3.8
Nash Marc

SVP Operations and R&D

Officer
21,590 -9.5%
0.80
US$17,272 		21,590 -9.5% 0.80 US$17,272
2025-01-22 2025-01-21 S Sale
3.8
Nash Marc

SVP Operations and R&D

Officer
356 -0.2%
0.80
US$285 		356 -0.2% 0.80 US$285
2025-01-22 2025-01-21 S Sale
4.1
Ahmed Nabeel

Chief Financial Officer

Officer
3,907 -1.5%
0.80
US$3,126 		3,907 -1.5% 0.80 US$3,126
2025-01-22 2025-01-21 S Sale
4.1
Ahmed Nabeel

Chief Financial Officer

Officer
29,474 -10.1%
0.80
US$23,579 		29,474 -10.1% 0.80 US$23,579
2025-01-22 2025-01-21 S Sale
4.1
Ahmed Nabeel

Chief Financial Officer

Officer
907 -0.3%
0.80
US$726 		907 -0.3% 0.80 US$726
2025-01-22 2025-01-21 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
18,449 -2.0%
0.80
US$14,759 		18,449 -2.0% 0.80 US$14,759
2025-01-22 2025-01-21 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
42,384 -4.4%
0.80
US$33,907 		42,384 -4.4% 0.80 US$33,907
2025-01-22 2025-01-21 S Sale
4.3
Trigg Leslie

Chair and CEO

Executive Director
4,403 -0.5%
0.80
US$3,522 		4,403 -0.5% 0.80 US$3,522
2025-01-21 2025-01-21 PrS Proposed sale
4.3
Trigg Leslie

Officer

Officer
65,236
0.80
US$52,189 		65,236 0.80 US$52,189
2025-01-21 2025-01-21 PrS Proposed sale
3.8
Nash Marc

Officer

Officer
23,221
0.80
US$18,577 		23,221 0.80 US$18,577
Explore more

More insider trading research around Outset Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America